Skip to content

Ocular Therapeutix

US · OCUL #2978 by market cap Listed 1970
5.57 -0.29 -4.95%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Quant vs Street three independent views, side by side

StockVane factor grade
C
Momentum strategy signal
Strong Sell
Analyst consensus
Buy

Signals diverge - worth digging into why.

Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.

Analyst consensus 8 analysts

Buy
Avg price target 25.14 +351.3%
Price target rangecurrent 5.57
Low14.00
Avg25.14
High31.00
Buy 100% Hold 0% Sell 0%
Recent ratings (25)
DateFirmAnalystRatingTarget
2026-11-10 Needham -- Buy 18.00
2026-11-10 H.C. Wainwright -- Buy 28.00
2026-11-09 BofA Securities -- Buy 27.00
2026-11-09 RBC Capital -- Buy 30.00
2026-10-20 H.C. Wainwright -- Buy 25.00
2026-10-13 BofA Securities -- Buy 27.00
2026-10-12 UBS -- Buy 14.00
2026-10-12 Piper Sandler -- Buy 31.00
2026-10-11 UBS -- Buy 14.00
2026-09-29 Piper Sandler -- Buy 31.00
2026-09-28 Needham -- Buy 18.00
2026-09-25 William Blair -- Buy --
2026-09-16 H.C. Wainwright -- Buy 25.00
2026-09-15 William Blair -- Buy --
2026-09-15 BofA Securities -- Buy 27.00
2026-08-26 Piper Sandler -- Buy 31.00
2026-08-20 BofA Securities -- Buy 27.00
2026-08-18 Clear Street -- Buy 28.00
2026-08-17 William Blair -- Buy --
2026-08-17 Needham -- Buy 18.00
2026-08-07 BofA Securities -- Buy 27.00
2026-08-04 Clear Street -- Buy 28.00
2026-08-04 H.C. Wainwright -- Buy 25.00
2026-08-03 TD Cowen -- Buy 20.00
2026-08-03 William Blair -- Buy --

Price target trend monthly average, last 3 years

Earnings history price reaction on the day

PeriodReport dateSessionOptions expectedActual move
2026/Q3 2026-11-09 -- ±16.25% +3.87% (in line)
2026/Q1 2026-05-05 -- ±12.79% -0.61% (in line)
2025/Q3 2025-11-04 -- ±10.96% -4.47% (in line)
2025/Q2 2025-08-05 -- ±15.69% -2.83% (in line)
2025/Q1 2025-05-05 -- ±14.42% -12.16% (in line)
2024/Q4 2025-03-03 -- ±19.86% -17.02% (in line)
2024/Q3 2024-11-14 -- ±15.29% -6.42% (in line)
2024/Q2 2024-08-07 -- ±23.07% +6.08% (in line)
2024/Q1 2024-05-07 After close ±16.69% -3.04% (in line)
2023/Q4 2024-03-11 After close ±13.75% -4.52% (in line)
2023/Q3 2023-11-07 After close ±21.37% -13.20% (in line)
2023/Q2 2023-08-07 After close ±22.34% -10.78% (in line)

"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Ocular Therapeutix discussion 0 comments

Add a comment